FAQ

Ganglioside GM1 Ab:PrThr:Pt:Ser:Ord:IF

Known as: Ganglioside GM1 Antibody:Presence or Threshold:Point in time:Serum:Ordinal:Immune Fluorescence, Ganglioside GM1 , Ac:Présence-Seuil:Temps ponctuel:Sérum:Ordinal:Immunofluorescence, S--monosialoganglioside GM1, Ig; ; IF 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2013
01219902013

Related topics

Related topics

6 relations
AntibodiesGanglioside GM1GangliosidesIMMUNE FLUORESCENCE
(More)

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Ganglioside GM1 Ab:PrThr:Pt:Ser:Ord:IF
Gangliosides
Serum
Antibodies
Ganglioside GM1
Serology (antibodies and most antigens except blood bank and infectious agents)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
[Determination of monosialogangliosides in sea cucumbers and sea urchins using liquid chromatography-tandem mass spectrometry].
An approach based on liquid chromatography-tandem mass spectrometry was developed for the quantification of monosialogangliosides… (More)
Is this relevant?
2003
2003
Formation of a membrane-active form of amyloid beta-protein in raft-like model membranes.
The conversion of soluble, nontoxic amyloid beta-protein (A beta) to aggregated, toxic A beta rich in beta-sheet structures is… (More)
Is this relevant?
2003
2003
Biochemical and molecular characterization of mutant hexosaminidase A in a Turkish family.
BACKGROUND Tay-Sachs disease is a form of monosialoganglioside triaose (GM2) gangliosidosis that results from the mutations in… (More)
Is this relevant?
1994
1994
Early treatment of stroke with monosialoganglioside GM-1. Efficacy and safety results of the Early Stroke Trial.
BACKGROUND AND PURPOSE The Early Stroke Trial (EST) is a randomized, double-blind, placebo-controlled trial to assess the effect… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1990
1990
Augmentation of mouse natural killer (NK) activity by GM-1/P, a processed form of monosialoganglioside GM-1.
We describe the immunomodulatory activity of GM-1/P a processed form of GM-1 (monosialoganglioside) extracted from ox brain… (More)
Is this relevant?
1990
1990
A pilot study with monosialoganglioside GM1 on acute cerebral ischemia.
Reported here are the results of an open controlled study on the use of GM1 in cases of ischemic strokes in its acute phase. A… (More)
Is this relevant?